Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-066844

Chairman & CEO bought 330 shares at $17.28 ($5,702)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-31 Purchase : show line 1 in the form +330 $17.28 $5,702 3,229,179 D
Open-market purchases · 330 sh · avg $17.28 · $5,702
Loading xslF345X04/tm2317506-1_4seq1.xml…